Growth Metrics

Resmed (RMD) Non-Current Deferred Tax Liability (2016 - 2025)

Resmed (RMD) has disclosed Non-Current Deferred Tax Liability for 16 consecutive years, with $78.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 1.29% year-over-year to $78.0 million, compared with a TTM value of $78.0 million through Dec 2025, up 1.29%, and an annual FY2025 reading of $77.7 million, down 2.09% over the prior year.
  • Non-Current Deferred Tax Liability was $78.0 million for Q4 2025 at Resmed, up from $77.6 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $113.0 million in Q1 2023 and bottomed at $9.7 million in Q2 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $60.4 million, with a median of $77.8 million recorded in 2025.
  • The sharpest move saw Non-Current Deferred Tax Liability plummeted 50.97% in 2021, then surged 955.13% in 2023.
  • Year by year, Non-Current Deferred Tax Liability stood at $12.9 million in 2021, then surged by 735.39% to $107.5 million in 2022, then dropped by 16.98% to $89.3 million in 2023, then dropped by 13.75% to $77.0 million in 2024, then increased by 1.29% to $78.0 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for RMD at $78.0 million in Q4 2025, $77.6 million in Q3 2025, and $77.7 million in Q2 2025.